Search

Search Constraints

You searched for: Author/Creator Simon, Krzysztof

Search Results

1. A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis. Issue 5 (29th January 2018)

2. Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study). Issue 5 (27th February 2015)

3. Chronic Hepatitis B Monitoring and Treatment Patterns in Five European Countries with Different Access and Reimbursement Policies. Issue 3 (April 2014)

4. Chronic Hepatitis B Treatment Initiation and Modification Patterns in Five European Countries: A 2-Year Longitudinal, Non-Interventional Study. Issue 3 (April 2014)

5. Hepatitis C virus load and expression of a unique subset of cellular genes in circulating lymphoid cells differentiate non‐responders from responders to pegylated interferon alpha–ribavirin treatment1. Issue 3 (21st December 2012)

6. Implementation of the web‐based calculator estimating odds ratio of severe COVID‐19 for unvaccinated individuals in a country with high coronavirus‐related death toll. Issue 1 (29th September 2022)

7. Is an 8‐week regimen of glecaprevir/pibrentasvir sufficient for all hepatitis C virus infected patients in the real‐world experience?. Issue 7 (23rd November 2020)

8. Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial. (August 2021)

9. Long‐term follow‐up of patients treated with entecavir and peginterferon add‐on therapy for HBeAg‐positive chronic hepatitis B infection: ARES long‐term follow‐up. Issue 1 (27th September 2018)

10. Low risk of HBV reactivation in a large European cohort of HCV/HBV coinfected patients treated with DAA. Issue 10 (2nd October 2020)